advertisement

WGA Rescources

11.13.5 Other (34)

Showing records 1 to 25

Display all abstracts in classification 11.13.5 Other

Search within classification 11.13.5 Other
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Belfort R
Clinical Therapeutics 2020; 42: 263-275
84761 Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension
Aref AA
Expert Review of Clinical Pharmacology 2019; 12: 1073-1079
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Wang N
Clinical Ophthalmology 2020; 14: 221-230
84729 Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
Lerner SF
Clinical Ophthalmology 2019; 13: 2411-2419
85153 The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis
Xing Y
PLoS ONE 2020; 15: e0229682
85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Wisely CE
Advances in Therapy 2020; 37: 1114-1123
84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Mehran NA
Eye 2020; 34: 72-88
84761 Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension
Geyman LS
Expert Review of Clinical Pharmacology 2019; 12: 1073-1079
85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Sheng H
Advances in Therapy 2020; 37: 1114-1123
84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Sinha S
Eye 2020; 34: 72-88
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Paula JS
Clinical Therapeutics 2020; 42: 263-275
84729 Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
Oddone F
Clinical Ophthalmology 2019; 13: 2411-2419
85153 The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis
Zhu L
PLoS ONE 2020; 15: e0229682
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Lu DW
Clinical Ophthalmology 2020; 14: 221-230
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Lopes Silva MJ
Clinical Therapeutics 2020; 42: 263-275
85153 The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis
Zhang K
PLoS ONE 2020; 15: e0229682
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Pan Y
Clinical Ophthalmology 2020; 14: 221-230
84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Razeghinejad R
Eye 2020; 34: 72-88
84729 Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
Lu DW
Clinical Ophthalmology 2019; 13: 2411-2419
84761 Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension
Zakieh AR
Expert Review of Clinical Pharmacology 2019; 12: 1073-1079
85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Heah T
Advances in Therapy 2020; 37: 1114-1123
84729 Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
Sanseau A
Clinical Ophthalmology 2019; 13: 2411-2419
85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Kim T
Advances in Therapy 2020; 37: 1114-1123
85153 The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis
Huang S
PLoS ONE 2020; 15: e0229682
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Astakhov Y
Clinical Ophthalmology 2020; 14: 221-230

Issue 21-1

Change Issue


advertisement

Oculus